Tsuyoshi Miyaoka
Izumo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
A multicenter, double-blind, randomized, controlled study of patients with treatment-resistant schizophrenia treated with yokukansan for 12 weeks.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: August 28, 2023
Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study.
Journal: Asian journal of psychiatry
Published: February 19, 2021
Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia: A case report.
Journal: Medicine
Published: December 24, 2020
Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin.
Journal: Pediatric research
Published: November 05, 2020
Low Serum Levels of Fibroblast Growth Factor 2 in Gunn Rats: A Hyperbilirubinemia Animal Model of Schizophrenic Symptoms.
Journal: CNS & neurological disorders drug targets
Published: December 10, 2019
Urinary biopyrrins and free immunoglobin light chains are biomarker candidates for screening at-risk mental state in adolescents.
Journal: Early intervention in psychiatry
Published: November 07, 2019
The Possible Causal Link of Periodontitis to Neuropsychiatric Disorders: More Than Psychosocial Mechanisms.
Journal: International journal of molecular sciences
Published: May 22, 2019
The effectiveness of electroconvulsive therapy for psychiatric symptoms and cognitive fluctuations similar to dementia with Lewy bodies: a case report.
Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
Published: April 23, 2019
Electroconvulsive shock restores the decreased coverage of brain blood vessels by astrocytic endfeet and ameliorates depressive-like behavior.
Journal: Journal of affective disorders
Published: February 21, 2019
Decreased Clostridium Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with Schizophrenia.
Journal: Case reports in psychiatry
Published: November 13, 2018
Parvalbumin-positive GABAergic interneurons deficit in the hippocampus in Gunn rats: A possible hyperbilirubinemia-induced animal model of schizophrenia.
Journal: Heliyon
Published: September 28, 2018
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial.
Journal: Clinical neuropharmacology
Published: September 21, 2018
Last Updated: 09/26/2026